Darya-Varia Laboratoria Tbk (JK:DVLA) — Market Cap & Net Worth
Market Cap & Net Worth: Darya-Varia Laboratoria Tbk (DVLA)
Darya-Varia Laboratoria Tbk (JK:DVLA) has a market capitalization of $105.00 Million (Rp1.79 Trillion) as of August 1, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #18951 globally and #318 in its home market, demonstrating a 1.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Darya-Varia Laboratoria Tbk's stock price Rp1600.00 by its total outstanding shares 1120000000 (1.12 Billion). See capital reinvestment ratio of Darya-Varia Laboratoria Tbk to understand how much of operating cash flow is reinvested back into capital assets.
Darya-Varia Laboratoria Tbk Market Cap History: 2015 to 2026
Darya-Varia Laboratoria Tbk's market capitalization history from 2015 to 2026. Data shows growth from $54.76 Million to $105.00 Million (5.46% CAGR).
Index Memberships
Darya-Varia Laboratoria Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$489.80 Billion | 0.02% | #310 of 864 |
Weight: Darya-Varia Laboratoria Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Darya-Varia Laboratoria Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Darya-Varia Laboratoria Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $54.76 Million | $1.31 Trillion | $107.89 Billion | 0.00x | 0.00x |
| 2016 | $75.73 Million | $1.45 Trillion | $152.08 Billion | 0.00x | 0.00x |
| 2017 | $88.78 Million | $1.58 Trillion | $162.25 Billion | 0.00x | 0.00x |
| 2018 | $92.92 Million | $1.70 Trillion | $200.65 Billion | 0.00x | 0.00x |
| 2019 | $113.20 Million | $1.81 Trillion | $221.78 Billion | 0.00x | 0.00x |
| 2020 | $127.43 Million | $1.83 Trillion | $162.07 Billion | 0.00x | 0.00x |
| 2021 | $151.47 Million | $1.90 Trillion | $146.51 Billion | 0.00x | 0.00x |
| 2022 | $136.57 Million | $1.92 Trillion | $149.38 Billion | 0.00x | 0.00x |
| 2023 | $102.40 Million | $1.89 Trillion | $146.34 Billion | 0.00x | 0.00x |
| 2024 | $105.00 Million | $2.09 Trillion | $156.15 Billion | 0.00x | 0.00x |
Competitor Companies of DVLA by Market Capitalization
Companies near Darya-Varia Laboratoria Tbk in the global market cap rankings as of August 1, 2026.
Key companies related to Darya-Varia Laboratoria Tbk by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
Darya-Varia Laboratoria Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Darya-Varia Laboratoria Tbk's market cap moved from $54.76 Million to $ 105.00 Million, with a yearly change of 5.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp105.00 Million | -3.03% |
| 2025 | Rp108.29 Million | +3.12% |
| 2024 | Rp105.00 Million | +2.54% |
| 2023 | Rp102.40 Million | -25.02% |
| 2022 | Rp136.57 Million | -9.84% |
| 2021 | Rp151.47 Million | +18.87% |
| 2020 | Rp127.43 Million | +12.57% |
| 2019 | Rp113.20 Million | +21.82% |
| 2018 | Rp92.92 Million | +4.66% |
| 2017 | Rp88.78 Million | +17.24% |
| 2016 | Rp75.73 Million | +38.28% |
| 2015 | Rp54.76 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Darya-Varia Laboratoria Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $105.00 Million USD |
| MoneyControl | $105.00 Million USD |
| MarketWatch | $105.00 Million USD |
| marketcap.company | $105.00 Million USD |
| Reuters | $105.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more